Clinical Trial Update: An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020) [Phase 3]

View source ↗

Summary

Phase 3 trial investigating Gardasil (qHPV vaccine) for reducing the incidence of anogenital warts in young men has completed with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Condylomata Acuminata

Drugs mentioned

• Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Condylomata Acuminata | Phase 3 | Status: COMPLETED | Results posted: 2009-11-19